
Max Healthcare Institute vs Narayana Hrudayalaya: Which Stock Should You Track
Max Healthcare MCap Rs 1,05,110 Cr, PE 72.87x, ROE 13.42%, D/E 0.32. Narayana Health MCap Rs 38,878 Cr, PE 47.61x, ROE 17.76%, D/E 1.29.
Updated: 10 Aug 2026 • 10:35 am
Posted by:

Max Healthcare vs Narayana Hrudayalaya is a comparison hospital chain investors look up when evaluating two leading Indian private healthcare operators. Max Healthcare is the largest listed multi-speciality hospital chain in North India, operating premium hospitals in Delhi NCR, and has acquired BLK Super Speciality Hospital and Sahara Hospital. Narayana Hrudayalaya is a Bengaluru-based hospital chain founded by cardiac surgeon Dr Devi Shetty, known for providing affordable healthcare at scale, with operations in India and the Cayman Islands.
This Max Healthcare Institute vs Narayana Hrudayalaya article covers reach and market position, key products, latest declared results and stock valuation. The Max Healthcare Institute vs Narayana Hrudayalaya data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Max Healthcare Institute vs Narayana Hrudayalaya: Reach and Market Position
On the Max Healthcare Institute side of the Max Healthcare Institute vs Narayana Hrudayalaya comparison, Max Healthcare operates 17 hospitals with 4,500+ beds, primarily in Delhi NCR (Saket, Patparganj, Vaishali, Shalimar Bagh, Mohali) and Kolkata, with recent acquisitions expanding the footprint. Market capitalisation is Rs 1,05,110 Cr.
Click Here – Get Free Investment Predictions
On the Narayana Hrudayalaya side of the Max Healthcare Institute vs Narayana Hrudayalaya comparison, Narayana Hrudayalaya operates 20+ hospitals in India across Bangalore, Kolkata, Ahmedabad and other cities, and a large facility in the Cayman Islands. Known for its low-cost cardiac surgery model. Market capitalisation is Rs 38,878 Cr.
Max Healthcare Institute vs Narayana Hrudayalaya: Key Products and Business Mix
In the Max Healthcare Institute vs Narayana Hrudayalaya product comparison, Max Healthcare Institute offers: Max Healthcare earns from inpatient procedures, OPD and diagnostic services across its North India hospital network. EPS is Rs 14.82. P/E is 72.87x, ROE 13.42 percent, D/E 0.32.
For Narayana Hrudayalaya in this Max Healthcare Institute vs Narayana Hrudayalaya breakdown: Narayana Hrudayalaya earns from cardiac surgeries, multi-speciality procedures and international patients at its Cayman Islands facility. EPS is Rs 39.96. P/E is 47.61x, ROE 17.76 percent, D/E 1.29.
Max Healthcare Institute vs Narayana Hrudayalaya: Latest Results
The Max Healthcare Institute vs Narayana Hrudayalaya results for Max Healthcare Institute: Max Healthcare has a market cap of Rs 1,05,110 Cr and P/E of 72.87x. ROE is 13.42 percent. Max is 2.7 times larger than Narayana by market cap and commands a premium for its North India branded hospital network.
The Max Healthcare Institute vs Narayana Hrudayalaya results for Narayana Hrudayalaya: Narayana Hrudayalaya has a market cap of Rs 38,878 Cr and P/E of 47.61x. ROE is 17.76 percent — higher than Max Healthcare — reflecting its higher bed utilisation and capital-efficient operating model. D/E of 1.29 is elevated for a hospital operator.
Compare Max Healthcare Institute and Narayana Hrudayalaya Fundamentals on the Univest Screener
Max Healthcare Institute vs Narayana Hrudayalaya: Stock and Valuation
The Max Healthcare Institute vs Narayana Hrudayalaya stock comparison uses the latest available market data from Groww. Investors tracking Max Healthcare Institute vs Narayana Hrudayalaya should verify current prices on NSE or BSE before trading.
Max Healthcare vs Narayana Hrudayalaya at current valuations: Max Healthcare trades at Rs 1,05,110 Cr market cap, P/E 72.87x, ROE 13.42 percent. Narayana trades at Rs 38,878 Cr market cap, P/E 47.61x, ROE 17.76 percent, D/E 1.29. Narayana has a higher ROE and lower P/E. Max Healthcare commands a premium for its Delhi NCR brand equity and recent acquisitions.
Max Healthcare Institute vs Narayana Hrudayalaya: Quick Comparison Table
The Max Healthcare Institute vs Narayana Hrudayalaya comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Max Healthcare Institute | Narayana Hrudayalaya |
|---|---|---|
| Sector | Premium multi-speciality (North India) | Affordable multi-speciality + Cayman Islands |
| Market Cap | Rs 1,05,110 Cr | Rs 38,878 Cr |
| P/E Ratio | 72.87x | 47.61x |
| ROE | 13.42% | 17.76% |
| Debt to Equity | 0.32 | 1.29 |
| Beds | 4,500+ (17 hospitals) | ~6,000+ (20+ hospitals) |
| Dividend | 0.19% yield | 0.24% yield |
Conclusion
The Max Healthcare Institute vs Narayana Hrudayalaya comparison above covers the key data points on reach, products, results and valuation. Max Healthcare Institute vs Narayana Hrudayalaya covers two distinct hospital chain models. Max Healthcare Institute vs Narayana Hrudayalaya shows Max as a premium Delhi NCR multi-speciality chain with a high ARPOB and acquisition-led growth. Narayana is known for its high-volume, affordable care model with strong returns from international cardiac patients. Max Healthcare Institute vs Narayana Hrudayalaya each benefit from India's under-penetrated private healthcare opportunity. Investors reviewing Max Healthcare Institute vs Narayana Hrudayalaya should check ARPOB, occupancy, bed expansion plans and pricing power. Max Healthcare Institute vs Narayana Hrudayalaya represent two complementary healthcare investment thesis — consult a SEBI-registered advisor.
Download the Univest iOS App or Univest Android App to track Max Healthcare Institute and Narayana Hrudayalaya live price and get daily stock recommendations.
SEBI Research Analyst Registration No. INH000013776
Frequently Asked Questions
What is Max Healthcare known for?
Ans. Max Healthcare is known for its premium multi-speciality hospitals in Delhi NCR — Max Smart Super Speciality Hospital Saket, Max Hospital Patparganj, BLK Super Speciality Hospital — offering oncology, cardiac, orthopaedic and transplant services.
What is Narayana Hrudayalaya known for?
Ans. Narayana Hrudayalaya, founded by Dr Devi Shetty, is known for affordable cardiac surgery at scale in India and a large international facility at Health City Cayman Islands. It pioneered high-volume, low-cost cardiac care globally.
What is ARPOB in hospital investing?
Ans. ARPOB stands for Average Revenue Per Occupied Bed. It is the primary efficiency metric for hospital chains, measuring revenue intensity per patient stay. Higher ARPOB with high occupancy implies pricing power and efficiency.
Does Max Healthcare pay dividends?
Ans. Max Healthcare pays a small dividend yield of approximately 0.19 percent.
Which hospital chain has a higher ROE?
Ans. Narayana Hrudayalaya has a higher ROE of 17.76 percent versus Max Healthcare at 13.42 percent, reflecting its more capital-efficient model.
Is Narayana Hrudayalaya in Nifty 50?
Ans. No. Neither Narayana Hrudayalaya nor Max Healthcare is in Nifty 50. Both are tracked in Nifty Healthcare and Nifty 500 indices.
How is India's hospital sector growing?
Ans. India has a significant under-penetration of private hospital beds relative to WHO standards. Growing urban middle class, health insurance penetration and medical tourism are key demand drivers for premium hospital chains.
Recent Articles

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Trades Within 2% of 52-Week High
10 August 2026

Transteel Seating Technologies Ltd. (TRANSTEEL-SM) Share Price Within 2% of 52-Week Low
10 August 2026

Jindal Drilling And Industries Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
10 August 2026

Sharp India Ltd. (SHARP) Share Price Trades Within 2% of 52-Week High
10 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Trades Within 2% of 52-Week High
Transteel Seating Technologies Ltd. (TRANSTEEL-SM) Share Price Within 2% of 52-Week Low
Jindal Drilling And Industries Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Sharp India Ltd. (SHARP) Share Price Trades Within 2% of 52-Week High
Mangalam Global Enterprise Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Popular this week
Transteel Seating Technologies Ltd. (TRANSTEEL-SM) Share Price Within 2% of 52-Week Low

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





